VDAC1 and metabolic dysfunction-associated steatotic liver disease: Therefore, we examined the expression of VDAC1 in the pancreas of the STZ/HFD-32 diet-fed mice, representing the NAFLD mouse on a diabetic background and the effect of R-Tf-D-LP4 peptide treatment as compared to the levels in islets from chow diet-fed mice (Figure 3).